SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-060140
Filing Date
2023-07-27
Accepted
2023-07-27 09:14:28
Documents
16
Period of Report
2023-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182424-8k_abvcbio.htm   iXBRL 8-K 28406
2 FORM OF WARRANT ea182424ex4-1_abvcbio.htm EX-4.1 108452
3 FORM OF SECURITIES PURCHASE AGREEMENT, BETWEEN THE COMPANY AND THE PURCHASERS ea182424ex10-1_abvcbio.htm EX-10.1 187564
4 PRESS RELEASE DATED JULY 27, 2023 ea182424ex99-2_abvcbio.htm EX-99.2 13088
5 GRAPHIC ex99-2_001.jpg GRAPHIC 2336
  Complete submission text file 0001213900-23-060140.txt   594979

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20230727.xsd EX-101.SCH 3021
7 XBRL LABEL FILE abvc-20230727_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE abvc-20230727_pre.xml EX-101.PRE 22363
10 EXTRACTED XBRL INSTANCE DOCUMENT ea182424-8k_abvcbio_htm.xml XML 3216
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231115474
SIC: 2834 Pharmaceutical Preparations